Omics-based large language models: A new engine for drug discovery innovation
文献类型:期刊论文
| 作者 | Sheng, Xia2,3; Zhang, Xiaoya2,3; Xing, Yuxin1,2,3; Shi, Yuqi2,3; Zeng, Chuanlong2,3; Tong, Xiaochu2,3; Zheng, Mingyue1,2,3; Li, Xutong2,3 |
| 刊名 | ACTA PHARMACEUTICA SINICA B
![]() |
| 出版日期 | 2026 |
| 卷号 | 16期号:1页码:122-136 |
| 关键词 | Large language model Representation learning Generalization Omics integration Single-cell Perturbation modeling Target identification Drug discovery |
| ISSN号 | 2211-3835 |
| DOI | 10.1016/j.apsb.2025.10.034 |
| 英文摘要 | Traditional drug discovery suffers from low efficiency and high attrition rates, largely due to the complexity and heterogeneity of human diseases. Omics technologies offer a systems-level perspective for uncovering disease mechanisms and identifying therapeutic targets, but present challenges such as high dimensionality, noise, and heterogeneity. Large language models (LLMs), originally developed for natural language processing, are emerging as powerful tools to address these issues by capturing complex patterns and inferring missing information from large, noisy datasets. We present a three-part framework: (1) Analyzing how LLM architectures and learning paradigms handle challenges specific to genomics, transcriptomics, and proteomics data; (2) Detailing LLM applications in key areas: uncovering disease mechanisms, identifying drug targets, predicting drug response, and simulating cellular behavior; (3) Discussing how insights from omics-integrated LLMs can inform the development of drugs targeting specific pathways, moving beyond single targets towards strategies grounded in underlying disease biology. This framework provides both conceptual insights and practical guidance for leveraging LLMs in omics-driven drug discovery and development. (c) 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| WOS关键词 | VIRTUAL CELL ; DNA ; PREDICTION ; MOLECULES ; PROTEIN |
| 资助项目 | Shanghai Municipal Science and Technology Major Project, National Key Research and Development Program of China[2023YFC2305904] ; Shanghai Municipal Science and Technology Major Project, National Key Research and Development Program of China[2022YFC3400504] ; Key Technologies R&D Program of Guangdong Province[2023B1111030004] ; Shanghai Sailing Program[24YF2755600] ; China Postdoctoral Science Foundation[2024M763421] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:001664852400001 |
| 出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/322679] ![]() |
| 专题 | 国家级研究中心_原创新药研究全国重点实验室 |
| 通讯作者 | Tong, Xiaochu; Zheng, Mingyue; Li, Xutong |
| 作者单位 | 1.Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 330106, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201103, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Sheng, Xia,Zhang, Xiaoya,Xing, Yuxin,et al. Omics-based large language models: A new engine for drug discovery innovation[J]. ACTA PHARMACEUTICA SINICA B,2026,16(1):122-136. |
| APA | Sheng, Xia.,Zhang, Xiaoya.,Xing, Yuxin.,Shi, Yuqi.,Zeng, Chuanlong.,...&Li, Xutong.(2026).Omics-based large language models: A new engine for drug discovery innovation.ACTA PHARMACEUTICA SINICA B,16(1),122-136. |
| MLA | Sheng, Xia,et al."Omics-based large language models: A new engine for drug discovery innovation".ACTA PHARMACEUTICA SINICA B 16.1(2026):122-136. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

